Naferon (Iron Sodium Citrate)

https://aihp.org/wp-content/uploads/2022/01/pdib-054a-naferon.jpg

Title

Naferon (Iron Sodium Citrate)

Description

Parke Davis collectible ink blotter from the 1940s advertising Naferon, iron sodium citrate. It is indicated for the treatment of anemias that respond to iron therapy, and contains 12.5% metalliciron in readily soluble form. It is available as Kapseals and Ampules; dosage information is given. The Parke-Davis identifier is bl-42-2.

Date

Rights

Copyright undetermined. For more information or for high-quality reproductions, please contact AIHP: aihp@aihp.org.
https://rightsstatements.org/page/UND/1.0/

Format

Language

eng

Identifier

pdib-054-naferon

Extent

7 X 3.5 inches

Temporal Coverage

Original Format

Citation

Parke, Davis & Company, “Naferon (Iron Sodium Citrate),” American Institute of the History of Pharmacy Digital Collection, accessed September 30, 2022, https://aihp.omeka.net/items/show/384.